NCT00375791View on ClinicalTrials.gov

Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

December 31, 2010

Study Completion Date

October 31, 2011

Conditions
Multiple Myeloma
Interventions
DRUG

perifosine

100 - 150 mg daily

DRUG

dexamethasone

20 mg twice weekly

Trial Locations (7)

22908

Investigative Site, Charlottesville

30322

Investigative Site, Atlanta

48103

Investigative Site, Ann Arbor

60611

Investigative Site, Chicago

91010

Investigative Site, Duarte

94704

Investigative Site, Berkeley

02115

Investigative Site, Boston

Sponsors

Lead Sponsor

AEterna Zentaris
All Listed Sponsors
lead

AEterna Zentaris

INDUSTRY